Rapid Micro Biosystems (RPID) Stock Price, News & Analysis

Rapid Micro Biosystems logo
$0.74 0.00 (-0.54%)
As of 03:31 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Rapid Micro Biosystems Stock (NASDAQ:RPID)

Advanced

Key Stats

Today's Range
$0.73
▼
$0.74
50-Day Range
$0.62
▼
$1.23
52-Week Range
$0.58
▼
$4.94
Volume
4.63 million shs
Average Volume
314,547 shs
Market Capitalization
$36.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.81
Consensus Rating
Hold

Company Overview

Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products.

The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.

Founded in 2006 and headquartered in Lexington, Massachusetts, Rapid Micro Biosystems serves customers in the United States and internationally. Its technology is intended to provide an automated alternative to traditional microbial testing methods.

AI Generated. May Contain Errors.

Rapid Micro Biosystems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

RPID MarketRank™: 
2.98726283667 of 5 stars

Rapid Micro Biosystems scored higher than 60% of companies evaluated by MarketBeat, and ranked 139th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Rapid Micro Biosystems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Rapid Micro Biosystems has a consensus price target of $1.81, representing about 145.9% upside from its current price of $0.74.

  • Amount of Analyst Coverage

    Rapid Micro Biosystems has only been the subject of 3 research reports in the past 90 days.

  • Read more about Rapid Micro Biosystems' stock forecast and price target.
  • Earnings Growth

    Earnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($0.94) to ($0.72) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rapid Micro Biosystems is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rapid Micro Biosystems is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Rapid Micro Biosystems has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.77% of the float of Rapid Micro Biosystems has been sold short.
  • Short Interest Ratio / Days to Cover

    Rapid Micro Biosystems has a short interest ratio ("days to cover") of 5.48.
  • Change versus previous month

    Short interest in Rapid Micro Biosystems has recently decreased by 12.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Rapid Micro Biosystems does not currently pay a dividend.

  • Dividend Growth

    Rapid Micro Biosystems does not have a long track record of dividend growth.

  • News Sentiment

    Rapid Micro Biosystems has a news sentiment score of -0.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Rapid Micro Biosystems this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.70% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.60% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Rapid Micro Biosystems' insider trading history.
Receive RPID Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RPID Stock News Headlines

Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
Rapid Micro Biosystems Reports Delayed Quarterly Filing
Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results
See More Headlines

RPID Stock Analysis - Frequently Asked Questions

Rapid Micro Biosystems' stock was trading at $2.90 at the beginning of the year. Since then, RPID shares have decreased by 74.6% and is now trading at $0.7370.

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) issued its quarterly earnings data on Monday, November, 16th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.01. The firm earned $9.53 million during the quarter, compared to analysts' expectations of $9.85 million. Rapid Micro Biosystems had a negative trailing twelve-month return on equity of 177.04% and a negative net margin of 145.56%.

Rapid Micro Biosystems (RPID) raised $150 million in an initial public offering (IPO) on Wednesday, July 14th 2021. The company issued 7,920,000 shares at a price of $18.00-$20.00 per share.

Top institutional shareholders of Rapid Micro Biosystems include State Street Corp (0.19%) and Pekin Hardy Strauss Inc. (0.08%). Insiders that own company stock include Robert G Jr Spignesi, Sean M Wirtjes, John J Addington Wilson, Richard S Kollender, Kirk Malloy, Melinda Litherland Pei and Longitude Capital Partners Ii,.
View institutional ownership trends
.

Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rapid Micro Biosystems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Star Bulk Carriers (SBLK), Tesla (TSLA), Intel (INTC), ASML (ASML) and Broadcom (AVGO).

Company Calendar

Last Earnings
11/16/2026
Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:RPID
CIK
1380106
Fax
N/A
Employees
171
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$0.75
Potential Upside/Downside
+146.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.12 million
Net Margins
-145.56%
Pretax Margin
-145.34%
Return on Equity
-177.04%
Return on Assets
-73.12%

Debt

Debt-to-Equity Ratio
1.08
Current Ratio
2.55
Quick Ratio
1.51

Sales & Book Value

Annual Sales
$33.59 million
Price / Sales
1.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.75 per share
Price / Book
0.98

Miscellaneous

Outstanding Shares
50,160,000
Free Float
43,790,000
Market Cap
$36.87 million
Optionable
Not Optionable
Beta
1.52
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:RPID) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners